FIELD: medicine. SUBSTANCE: preparation has gamma-globulin (0.6 mg), histamine (0.0002 mg) and serotonin (0.002 mg) per 1 ml saline solution. EFFECT: increased therapeutic effect, prolonged remission, broadened sphere of usage. 2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR ALLERGIC DISEASES TREATMENT | 0 | 
 | SU1792329A3 | 
| METHOD OF TREATMENT OF ATOPIC DERMATITIS | 2007 | 
 | RU2340348C1 | 
| METHOD FOR ALLERGIC DISEASE TREATMENT | 0 | 
 | SU1793923A3 | 
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 | 
 | RU2411048C1 | 
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 | 
 | RU2395305C1 | 
| METHOD FOR PREVENTING AUTOIMMUNE THYROIDITIS IN THE COURSE OF ALLERGEN-SPECIFIC THERAPY | 2021 | 
 | RU2775129C1 | 
| METHOD OF TREATING ALLERGIC DISEASES | 2020 | 
 | RU2742976C1 | 
| METHOD FOR TREATING THE CASES OF ALLERGIC DISEASES | 2004 | 
 | RU2250773C1 | 
| METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 | 
 | RU2633343C2 | 
| METHOD FOR TREATING INFECTIOUS ALLERGIC RHINOSINUSOPATHY | 1996 | 
 | RU2121359C1 | 
Authors
Dates
1996-02-27—Published
1992-09-15—Filed